French Observatory of Familial Hypercholesterolemia in Cardiology
- Conditions
- Familial Hypercholesterolemia
- Registration Number
- NCT02013713
- Lead Sponsor
- French Cardiology Society
- Brief Summary
The Family Hypercholesterolemia remains poorly diagnosed disease with an outlet sometimes suboptimal care. However, the Family Hypercholesterolemia exposes patients concerned at increased cardiovascular risk.
The frequency of familial hypercholesterolemia in cardiologic is little studied and remains unknown, and there is little data on the profile of patients, diagnostic methods and management.
Main objectives:
* Establish a monitoring patients with hypercholesterolemia Family cardiology in France
* Characterize the Family hypercholesterolemia in cardiology, including assessing the frequency of the most severe forms, which are at higher cardiovascular risk.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 31
- coronary patients
- who agreed to participate
- high LDL-c levels: * LDL-c> = 1.9g / l without lipid lowering treatment according to the diagnostic score of Family Hypercholesterolemia these coronary patients with LDL> 1.9g / l may possibly or probably be achieved Hypercholesterolemia Family.
or
* LDL-c> = 1.6g / l in lipid-lowering treatment, the reduction of LDL-c average expected under standard lipid-lowering therapy (statin alone) being 30-40% of these patients had therefore pretreatment levels greater than 2 g / l or greater than 2.5 g / l and may possibly or probably be achieved Family Hypercholesterolemia after the diagnostic score.
- Expressed refusal to participate in the observatory
- Age ≤ 18
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of the Family Hypercholesterolemia in cardiology 1 day Number of Family Hypercholesterolemia among patients with LDL-C\> 1.9g / l without hypoglycemic treatment or\> 1.6g / l in lipid-lowering therapy
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
European Hospital Georges Pompidou
🇫🇷Paris, France